Trial status
RECRUITMENT
This protocol references version 1.2 from July 9, 2021. The first participant was screened on November 3, 2021. The first participant was enrolled on November 10, 2021. The study is expected to conclude recruitment on April 24, 2023, with all enrolled participants followed quarterly for 18 months thereafter.